Pith. sign in

REVIEW 5 major objections 5 minor 104 references

Immunometabolism at the Crossroads of Infection: Mechanistic and Systems-Level Perspectives from Host and Pathogen

T0 review · 5 major / 5 minor · reviewed 2026-08-07 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read Immune-cell metabolism is a pathogen-specific battle and a drug target.

desk verdict A clear, well-organized review whose broad metabolic narrative is sound but whose citation list is broken enough to undermine its reliability as a synthesis. read the letter →

arxiv 2506.02236 v1 pith:CGU76NR7 submitted 2025-06-02 q-bio.CB

Sunayana Malla , Nabia Shahreen , Rajib Saha This is my paper
classification q-bio.CB
keywords ImmunometabolismInnateimmunecellsAdaptiveVirusBacteriaFungiPathogensMetabolicreprogramming
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This review argues that immune cells are not passive energy users: their metabolic programs—glycolysis, the TCA cycle, oxidative phosphorylation, fatty acid oxidation, and amino acid metabolism—actively decide how they respond to infection. The authors synthesize evidence that macrophages, dendritic cells, T cells, and other immune cells rewire these pathways in pathogen-specific ways, and that bacteria, viruses, fungi, and parasites exploit or subvert the same pathways to survive. They further claim that combining genome-scale metabolic modeling, flux analysis, and multi-omics with experimental validation has identified host and pathogen metabolic bottlenecks that can be targeted therapeutically. As a review, the paper presents no new measurements; its claim is that the accumulated evidence coheres into a practical framework for modulating metabolism to improve infection outcomes.

What carries the argument

The load-bearing object is the metabolic network map of an immune cell and its pathogen, read through the glycolysis–OXPHOS–TCA cycle axis and through amino acid pathways centered on arginine, tryptophan, and serine. The methodological engine is genome-scale metabolic modeling (GSM), a computational reconstruction of an organism's full set of metabolic reactions, used with flux balance analysis to simulate how pathway activity shifts under infection and constrained by multi-omics data. The named molecular switches carrying the argument are HIF-1α and mTOR, which drive the glycolytic shift; IRG1 and its product itaconate, an antimicrobial metabolite; IDO, which enforces tryptophan starvation; and arginase-1, which diverts arginine away from nitric-oxide production.

What would settle it

Read the cited primary papers behind six load-bearing statements in the review (for instance, the Salmonella PPARδ/FAO persistence statement, the Mtb microRNA-21/PFKFB3 mechanism, the Candida β-glucan trained-immunity pathway, and the metformin tuberculosis trial) and record whether the attributed result actually appears in the cited source. If the attributed findings are absent from their cited sources in most cases, the review's synthetic claim is falsified.

Watch

Extended reading notes

Core claim

The paper's central claim is that immunometabolism gives a unifying, bidirectional account of infection: immune cells and pathogens contend over the same metabolic resources, and the outcome of that contention decides whether the host clears the pathogen or the pathogen persists. On the host side, pro-inflammatory macrophages switch to glycolysis with a disrupted TCA cycle, M2 macrophages and memory T cells rely on OXPHOS and fatty acid oxidation, and activated dendritic cells upregulate glycolysis; on the pathogen side, SARS-CoV-2 and HIV push cells toward aerobic glycolysis, M. tuberculosis suppresses host glycolysis through microRNA-21 targeting PFKFB3, Salmonella reprograms serine metabolism through effector SopE2, and Toxoplasma and Leishmania manipulate tryptophan and arginine pathways. The review's distinct claim is that these observations cohere rather than remain a list of examples: genome-scale metabolic models, when integrated with transcriptomic, metabolomic, and flux data and tested experimentally, converge on the same metabolic chokepoints—itaconate, lactate, arginine, tryptophan, mycolic-acid synthesis—so that host-directed and pathogen-targeted therapies become plausible.

Load-bearing premise

The entire synthesis depends on each cited reference actually supporting the specific claim it is attached to; where that link fails, the review's statements cannot be traced to evidence.

Editorial extensions

If this is right

  • If the synthesis holds, drugs that shift immune metabolism—metformin toward OXPHOS, 2-deoxy-D-glucose against glycolysis, statins against lipid-dependent pathogen survival—become testable adjuncts in tuberculosis, viral infections, and sepsis.
  • Pathogen auxotrophies such as Toxoplasma's dependence on host tryptophan imply that reinforcing nutrient-withdrawal mechanisms such as IDO activity could suppress intracellular pathogens.
  • Metabolic biomarkers such as lactate, itaconate, and kynurenine could stratify patients in trials of metabolic modulators, making adjunct-therapy effects visible.
  • Bidirectional computation, in which immune-cell and pathogen metabolic models are coupled, could predict nutrient bottlenecks and synthetic-lethal vulnerabilities before experiments.
  • The same metabolic switches that control infection may also apply to autoimmunity and cancer, because shifting regulatory T cells and macrophages between OXPHOS and glycolysis changes whether they dampen or drive inflammation.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • A reader could infer from the paper's pathogen-specific framing that no single metabolic therapy will work across infections: the same glycolytic shift that helps macrophages kill bacteria may be what a virus exploits, so therapy may need to be pathogen-aware.
  • The review's repeated emphasis on understudied secondary pathways such as arachidonic acid and leukotrienes suggests a testable extension: inhibiting these pathways might resolve inflammatory damage without weakening the glycolysis-dependent microbicidal response.
  • One could extend the paper's dual-transcriptome logic to predict that community-scale metabolic models of host, pathogen, and microbiome together would reveal three-way nutrient competitions, not just two-way ones; the paper only gestures at this.
  • A prospective observational study measuring plasma itaconate, lactate, and kynurenine before and during metformin or 2-DG treatment would directly test the paper's claim that these metabolites can predict therapeutic response.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

5 major / 5 minor

Summary. This manuscript is a narrative review of immunometabolism in host immune cells and during bacterial, viral, fungal, and parasitic infections. It is organized into sections on innate and adaptive immunity, pathogen-specific metabolic reprogramming, therapeutic directions, future directions, and a conclusion, and it claims to synthesize experimental, computational, and integrative methodologies. The paper presents no primary data, new derivations, or fitted parameters; its evidentiary basis is entirely the cited literature.

Significance. If the sourcing were reliable, the review would be a useful, if not deeply novel, survey of an active field. Its organization by pathogen class and its attention to genome-scale modeling and integrative multi-omics are helpful framing devices, and the high-level pathway assignments (glycolysis in M1 macrophages and effector T cells, OXPHOS/FAO in M2 macrophages and memory T cells, glycolysis-driven trained immunity) are consistent with broad textbook consensus. However, the repeated citation-reference mismatches documented below mean that the review's specific, checkable content is currently unreliable. Because a narrative review's contract with the reader is that each stated finding can be traced to the cited source, the paper cannot serve as a dependable entry point to the primary literature without extensive correction.

major comments (5)
  1. [Introduction, after the first two paragraphs] The sentence 'Foundational studies by Mathis & Shoelson. (2011)10, Tannahill et al. (2013)11, and Kidani et al. (2014)12' cites reference 10 as Mathis and Shoelson, but reference 10 is Tan et al., Food Chemistry 376, 131860 (2022), an edible-plants paper. The actual Mathis and Shoelson paper appears as reference 2. The foundational claim is therefore attributed to the wrong source, and a reader checking the reference list will not find the stated work.
  2. [Section 2.2, Salmonella paragraph] The statement that 'Salmonella persistence in macrophages depends on host fatty acid oxidation driven by PPARδ signaling 63,64' cites reference 63, which is Kostic et al., Cell Host Microbe 14, 207–215 (2013), a Fusobacterium nucleatum tumorigenesis paper. That reference does not address Salmonella or PPARδ signaling. The claim is left supported by at most one reference (64), and the PPARδ-specific mechanism cannot be traced to the cited pair.
  3. [Section 2.3, Candida trained immunity] The sentence on β-glucan-trained immunity cites references 74–75. Reference 74 is Bell and McFadden, 'Viruses for Tumor Therapy,' which is unrelated to fungal β-glucans and trained immunity; only reference 75 (Cheng et al.) supports the claim. The subsequent sentence on multi-omics validation cites reference 84, which is Mayeuf-Louchart et al., a brown-adipocyte glycogen paper, not a study of β-glucan-trained monocyte multi-omics. These mismatches make the section's central claims untraceable.
  4. [Section 2.3, Leishmania and CandidaNet paragraphs] The Leishmania arginine-metabolism claim cites references 79–80, but reference 79 is Li et al. on TBK1 and HDAC9 in antiviral innate immunity, not a Leishmania study. Similarly, the sentence introducing the Candida albicans genome-scale reconstruction 'CandidaNet' cites reference 82, which is Khateb et al., an AML/RNF5 paper. Neither citation corresponds to the stated finding, so the computational claims in this subsection cannot be independently verified from the reference list.
  5. [Table 1] Multiple rows in Table 1 cite references that do not support the listed metabolic signatures. For example, the Natural Killer cell row cites reference 75 (trained immunity) for 'role of metals such as iron'; the Mast Cell row cites reference 11 (succinate and HIF-1α) for glycolysis and OXPHOS; and the T cell row cites references 55, 77, 94, and 99, none of which are T cell metabolic profiling studies. Because Table 1 is the paper's central comparative summary, these mismatches propagate the traceability problem into the main reference resource of the review.
minor comments (5)
  1. [Introduction] The phrase 'Mathis & Shoelson. (2011)10' contains a stray period and an erroneous citation number; see the related major comment.
  2. [Section 2.2, Treponema/Neisseria sentence] The parenthetical '( scavenges host cholesterol)65,66' appears in the middle of the Neisseria gonorrhoeae clause and seems to be a misplaced fragment from the preceding Treponema pallidum sentence; it should be removed or repositioned.
  3. [References and in-text numbering] The reference numbering in the text does not match the reference list in several places beyond the major examples (e.g., Table 1 uses references 36 and 37 for SARS-CoV-2 metabolic features, but those are genome-scale-model antiviral-target papers rather than the cited glucose-uptake study). A full citation audit is needed.
  4. [Table 1] Table 1 contains typographical errors such as 'MACROPAHGES' and a duplicated citation '96,96' in the Salmonella row; these should be corrected.
  5. [Acknowledgments and Figure 1] The Acknowledgments state that 'meta-analysis was conducted by obtaining publication data from google scholar.' This is not a meta-analysis, and the methods behind the Figure 1 publication-count graph (search term, date, inclusion criteria, and retrieval procedure) should be described precisely or the wording changed.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: the paper is a narrative review with no derivation, fitted parameters, or self-derived predictions to reduce.

full rationale

This manuscript is a review article, not a derivation or modeling study. It makes no formal claims of the form 'X predicts Y,' fits no parameters to data, and presents no equations whose outputs could be equivalent to their inputs by construction. The central content is a set of summarized literature claims about immunometabolism, each supported by citations to external experimental and computational work. The authors do cite their own prior modeling papers (refs 38, 69-71), but those citations function as ordinary references to previously published, externally accessible results, not as load-bearing justifications for a novel conclusion advanced by this review. Nothing in the text reduces to a self-citation chain or to a renamed fit: the review's claims about macrophage, T cell, viral, bacterial, and fungal metabolism are summaries of the cited literature. The citation-reference mismatches noted by the skeptical reader (e.g., ref 10 is a Food Chemistry paper rather than Mathis & Shoelson; ref 63 is a Fusobacterium paper rather than the Salmonella PPAR-delta study) are serious traceability and correctness problems for a review whose evidentiary value depends on accurate sourcing, but they are not instances of circularity: a wrong or mismatched citation does not make an argument circular. Because there is no derivation chain to walk, no fitted parameter renamed as a prediction, and no uniqueness theorem imported from the authors' prior work, the appropriate circularity finding is none. Score 0 reflects the absence of internal circularity, while the sourcing issues should be handled as factual/verification concerns rather than circularity.

Assumptions & free parameters 0 free parameters · 1 assumptions · 0 invented entities

This is a review, so it introduces no free parameters and no invented entities. The only load-bearing premise is that the citation-to-claim mapping is accurate, which is demonstrably weak in several places.

assumptions (1)
  • domain assumption The cited references accurately support the statements attributed to them.
    Multiple citations do not match their attributed claims, including references 10, 63, 74, 79, 82, and 84. Therefore this assumption is partly violated and the review's factual statements cannot be reliably traced to the listed sources.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Immunometabolism at the Crossroads of Infection: Mechanistic and Systems-Level Perspectives from Host and Pathogen." pith.science (2026). https://pith.science/paper/CGU76NR7

@misc{pith2026250602236,
  author       = {Pith},
  title        = {Pith review of: Immunometabolism at the Crossroads of Infection: Mechanistic and Systems-Level Perspectives from Host and Pathogen},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/CGU76NR7}},
  note         = {Machine review of arXiv:2506.02236}
}
read the original abstract

The emerging field of immunometabolism has underscored the central role of metabolic pathways in orchestrating immune cell function. Far from being passive background processes, metabolic activities actively regulate key immune responses. Fundamental pathways such as glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation critically shape the behavior of immune cells, influencing macrophage polarization, T cell activation, and dendritic cell function. In this review, we synthesize recent advances in immunometabolism, with a focus on the metabolic mechanisms that govern the responses of both innate and adaptive immune cells to bacterial, viral, and fungal pathogens. Drawing on experimental, computational, and integrative methodologies, we highlight how metabolic reprogramming contributes to host defense in response to infection. These findings reveal new opportunities for therapeutic intervention, suggesting that modulation of metabolic pathways could enhance immune function and improve pathogen clearance.

Figures

Figures reproduced from arXiv: 2506.02236 by the authors.

Figure 1
Figure 1. The figure highlights the contribution of metabolism to boost immune response from [PITH_FULL_IMAGE:figures/full_fig_p028_1.png] view at source ↗
Figure 1
Figure 1. [PITH_FULL_IMAGE:figures/full_fig_p029_1.png] view at source ↗

Discussion (0). Sign in to comment.

Reference graph

Works this paper leans on

104 extracted references · 80 canonical work pages

  1. [1]

    Immunometabolism Advances in Host Immune cells 1.1. Innate Immune Cells Advances in immunometabolism have highlighted how metabolic pathways such as glycolysis, OXPHOS, FAO, and TCA cycle are intricately tied to the function and plasticity of innate immune cells. Early experimental studies paved the way to understand and explore the true contribution of m...

    2019

  2. [2]

    arms races

    Immunometabolism Advances in Pathogen-Specific Interactions 2.1. Viral Infections Viruses universally reprogram host cell metabolism to support replication. Experimental studies have demonstrated that many viruses, including SARS-CoV-2 and HIV-1, induce significant metabolic shifts towards aerobic glycolysis, analogous to the Warburg effect53 . SARS-CoV-2...

  3. [3]

    Warburg-like

    Therapeutic Directions 3.1. Host-Directed Metabolic Therapies Advances in immunometabolism have spurred host -directed therapies that reprogram the host’s metabolism to combat infection. One strategy is to inhibit glycolysis, a pathway often hijacked by both immune cells and pathogens during infection. 2 -Deoxy-D-glucose (2-DG), a glucose analog that bloc...

  4. [4]

    Future Direction & Our Perspective While current research in immunometabolism has greatly expanded our understanding of central carbon metabolism in host defense, substantial gaps remain in our grasp of secondary metabolic pathways and their context -dependent roles. Fatty acids, amino acid derivatives, and lipid mediators, such as prostaglandins and leuk...

  5. [5]

    No longer viewed as passive energy consumers, immune cells actively rewire their metabolic programs to control effector functio n, proliferation, and differentiation

    Conclusion Immunometabolism has redefined our understanding of how immune cells sense, respond to, and shape their environment during infection. No longer viewed as passive energy consumers, immune cells actively rewire their metabolic programs to control effector functio n, proliferation, and differentiation. This reprogramming is context -dependent: gly...

  6. [6]

    & Rathmell, J

    Makowski, L., Chaib, M. & Rathmell, J. C. Immunometabolism: From basic mechanisms to translation. Immunol. Rev. 295, 5–14 (2020)

    2020

  7. [7]

    & Shoelson, S

    Mathis, D. & Shoelson, S. E. Immunometabolism: an emerging frontier. Nat. Rev. Immunol. 11, 81–83 (2011)

    2011

  8. [8]

    Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther. 8, 1–35 (2023)

    2023

Show all 104 references
  1. [9]

    & Shalek, A

    Satija, R. & Shalek, A. K. Heterogeneity in Immune Responses – From Populations to Single Cells. Trends Immunol. 35, 219–229 (2014)

    2014

  2. [10]

    G., Ostuni, R

    Ng, L. G., Ostuni, R. & Hidalgo, A. Heterogeneity of neutrophils. Nat. Rev. Immunol. 19, 255–265 (2019)

    2019

  3. [11]

    Kesapragada, M. et al. Deep learning classification for macrophage subtypes through cell migratory pattern analysis. Front. Cell Dev. Biol. 12, (2024)

    2024

  4. [12]

    Hotamisligil, G. S. Foundations of Immunometabolism and Implications for Metabolic Health and Disease. Immunity 47, 406–420 (2017)

    2017

  5. [13]

    S., Warrington, R., Watson, W

    Marshall, J. S., Warrington, R., Watson, W. & Kim, H. L. An introduction to immunology and immunopathology. Allergy Asthma Clin. Immunol. 14, 49 (2018)

    2018

  6. [14]

    & Shlomchik, M

    Charles A Janeway, J., Travers, P., Walport, M. & Shlomchik, M. J. Principles of innate and adaptive immunity. in Immunobiology: The Immune System in Health and Disease. 5th edition (Garland Science, 2001)

    2001

  7. [15]

    Tan, W. et al. Immunometabolism modulation, a new trick of edible and medicinal plants in cancer treatment. Food Chem. 376, 131860 (2022)

    2022

  8. [16]

    Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013)

    2013

  9. [17]

    & Bensinger, S

    Kidani, Y. & Bensinger, S. J. Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus. J. Clin. Invest. 124, 482–485 (2014)

    2014

  10. [18]

    & Kuchroo, V

    Purohit, V., Wagner, A., Yosef, N. & Kuchroo, V. K. Systems-based approaches to study immunometabolism. Cell. Mol. Immunol. 19, 409–420 (2022)

    2022

  11. [19]

    Chakraborty, A. K. A Perspective on the Role of Computational Models in Immunology. Annu. Rev. Immunol. 35, 403–439 (2017)

    2017

  12. [20]

    Wang, X., Fan, D., Yang, Y., Gimple, R. C. & Zhou, S. Integrative multi-omics approaches to explore immune cell functions: Challenges and opportunities. iScience 26, 106359 (2023)

    2023

  13. [21]

    & Medzhitov, R

    Wang, A., Luan, H. & Medzhitov, R. An Evolutionary Perspective on Immunometabolism. Science 363, eaar3932 (2019)

    2019

  14. [22]

    J., Gauthier, T., Palomares, F., López-Enríquez, S

    Basso, P. J., Gauthier, T., Palomares, F., López-Enríquez, S. & Tsai, S. Editorial: Immunometabolism: bridging the gap between immunology and nutrition. Front. Nutr. 11, (2024)

    2024

  15. [23]

    & Brüne, B

    Namgaladze, D. & Brüne, B. Rapid glycolytic activation accompanying innate immune responses: mechanisms and function. Front. Immunol. 14, (2023)

    2023

  16. [24]

    Bossche, J. V. den, O’Neill, L. A. & Menon, D. Macrophage Immunometabolism: Where Are We (Going)? Trends Immunol. 38, 395–406 (2017)

    2017

  17. [25]

    & Newsholme, E

    Newsholme, P., Curi, R., Gordon, S. & Newsholme, E. A. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem. J. 239, 121–125 (1986)

    1986

  18. [26]

    Hard, G. C. Some Biochemical Aspects of the Immune Macrophage. Br. J. Exp. Pathol. 51, 97–105 (1970)

    1970

  19. [27]

    & Keshav, S

    Stein, M. & Keshav, S. The versatility of macrophages. Clin. Exp. Allergy 22, 19–27 (1992)

    1992

  20. [28]

    & Chi, H

    Guo, C. & Chi, H. Chapter Four - Immunometabolism of dendritic cells in health and disease. in Advances in Immunology (eds. Alt, F. W. & Murphy, K. M.) vol. 160 83–116 (Academic Press, 2023)

    2023

  21. [29]

    H., Wang, L

    Møller, S. H., Wang, L. & Ho, P.-C. Metabolic programming in dendritic cells tailors immune responses and homeostasis. Cell. Mol. Immunol. 19, 370–383 (2022)

    2022

  22. [30]

    Adamik, J. et al. Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells. Nat. Commun. 13, 5184 (2022)

    2022

  23. [31]

    Littwitz-Salomon, E. et al. Metabolic requirements of NK cells during the acute response against retroviral infection. Nat. Commun. 12, 5376 (2021)

    2021

  24. [32]

    P., Anderson, C

    Mendoza, R. P., Anderson, C. C., Roede, J. R. & Brown, J. M. Comparing mast cell immunometabolism shifts induced by IgE mediated and non-IgE mediated degranulation. J. Immunol. 202, 54.14 (2019)

    2019

  25. [33]

    P., Fudge, D

    Mendoza, R. P., Fudge, D. H. & Brown, J. M. Cellular Energetics of Mast Cell Development and Activation. Cells 10, 524 (2021)

    2021

  26. [34]

    Porter, L. et al. Metabolic Profiling of Human Eosinophils. Front. Immunol. 9, (2018)

    2018

  27. [35]

    Jeon, J.-H., Hong, C.-W., Kim, E. Y. & Lee, J. M. Current Understanding on the Metabolism of Neutrophils. Immune Netw. 20, (2020)

    2020

  28. [36]

    Thind, M. K. et al. A metabolic perspective of the neutrophil life cycle: new avenues in immunometabolism. Front. Immunol. 14, (2024)

    2024

  29. [37]

    Gotoh, K. et al. Mitochondrial p32/C1qbp Is a Critical Regulator of Dendritic Cell Metabolism and Maturation. Cell Rep. 25, 1800-1815.e4 (2018)

    2018

  30. [38]

    & Chen, W

    Gauthier, T. & Chen, W. Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections. Front. Immunol. 13, (2022)

    2022

  31. [39]

    M., King, Z

    Bordbar, A., Monk, J. M., King, Z. A. & Palsson, B. O. Constraint-based models predict metabolic and associated cellular functions. Nat. Rev. Genet. 15, 107–120 (2014)

    2014

  32. [40]

    E., Schellenberger, J., Palsson, B

    Bordbar, A., Lewis, N. E., Schellenberger, J., Palsson, B. Ø. & Jamshidi, N. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol. 6, 422 (2010)

    2010

  33. [41]

    & Dräger, A

    Renz, A., Widerspick, L. & Dräger, A. FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2. Bioinformatics 36, i813–i821 (2020)

    2020

  34. [42]

    & Dräger, A

    Renz, A., Widerspick, L. & Dräger, A. Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target. Genes 12, 796 (2021)

    2021

  35. [43]

    A., Acharya, B., Chowdhury, R

    Malla, S., Sajeevan, K. A., Acharya, B., Chowdhury, R. & Saha, R. Dissecting metabolic landscape of alveolar macrophage. Sci. Rep. 14, 30383 (2024)

    2024

  36. [44]

    & Sealfon, S

    Zaslavsky, E., Hayot, F. & Sealfon, S. C. Computational Approaches to Understanding Dendritic Cell Responses to Influenza Virus Infection. Immunol. Res. 54, 160–168 (2012)

    2012

  37. [45]

    S., Puniya, B

    Aghamiri, S. S., Puniya, B. L., Amin, R. & Helikar, T. A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery. Front. Immunol. 14, (2023)

    2023

  38. [46]

    G., Huang, L

    Russell, D. G., Huang, L. & VanderVen, B. C. Immunometabolism at the interface between macrophages and pathogens. Nat. Rev. Immunol. 19, 291– 304 (2019)

    2019

  39. [47]

    X., Sové, R

    Zhao, C., Medeiros, T. X., Sové, R. J., Annex, B. H. & Popel, A. S. A data- driven computational model enables integrative and mechanistic characterization of dynamic macrophage polarization. iScience 24, 102112 (2021)

    2021

  40. [48]

    Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology

    Chi, H. Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology. Cell. Mol. Immunol. 19, 299–302 (2022)

    2022

  41. [49]

    D., O’Sullivan, D

    Buck, M. D., O’Sullivan, D. & Pearce, E. L. T cell metabolism drives immunity. J. Exp. Med. 212, 1345–1360 (2015)

    2015

  42. [50]

    Levine, L. S. et al. Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response. Immunity 54, 829-844.e5 (2021)

    2021

  43. [51]

    Ron-Harel, N. et al. Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation. Cell Metab. 24, 104– 117 (2016)

    2016

  44. [52]

    Ma, E. H. et al. Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells. Immunity 51, 856-870.e5 (2019)

    2019

  45. [53]

    & Spear, S

    Capasso, M., Rashed Alyahyawi, A. & Spear, S. Metabolic Control of B Cells: More Questions than Answers. Front. Immunol. 6, (2015)

    2015

  46. [54]

    Martinis, E. et al. B cell immunometabolism in health and disease. Nat. Immunol. 26, 366–377 (2025)

    2025

  47. [55]

    Rosser, E. C. & Mauri, C. The emerging field of regulatory B cell immunometabolism. Cell Metab. 33, 1088–1097 (2021)

    2021

  48. [56]

    Puniya, B. L. et al. A Mechanistic Computational Model Reveals That Plasticity of CD4+ T Cell Differentiation Is a Function of Cytokine Composition and Dosage. Front. Physiol. 9, (2018)

    2018

  49. [57]

    & Cui, G

    Ma, S., Ming, Y., Wu, J. & Cui, G. Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell. Mol. Immunol. 21, 419–435 (2024)

    2024

  50. [58]

    Sanchez, E. L. & Lagunoff, M. Viral activation of cellular metabolism. Virology 479–480, 609–618 (2015)

    2015

  51. [59]

    Codo, A. C. et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis. Cell Metab. 32, 437-446.e5 (2020)

    2020

  52. [60]

    https://journals.asm.org/doi/10.1128/mbio.00757-18

    Induction of HIF-1α by HIV-1 Infection in CD4+ T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation | mBio. https://journals.asm.org/doi/10.1128/mbio.00757-18

    doi

  53. [61]

    Mikaeloff, F. et al. Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection. Commun. Biol. 5, 1–12 (2022)

    2022

  54. [62]

    Cheng, K. et al. Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐ induced metabolic changes and antiviral targets. Mol. Syst. Biol. 17, e10260 (2021)

    2021

  55. [63]

    & Tomar, S

    Mahajan, S., Choudhary, S., Kumar, P. & Tomar, S. Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens. Bioorg. Med. Chem. 46, 116356 (2021)

    2021

  56. [64]

    Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636–1643 (2020)

    2020

  57. [65]

    Baďurová, L. et al. 2-Deoxy-D-glucose inhibits lymphocytic choriomeningitis virus propagation by targeting glycoprotein N-glycosylation. Virol. J. 20, 108 (2023)

    2023

  58. [66]

    Hackett, E. E. et al. Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21. Cell Rep. 30, 124-136.e4 (2020)

    2020

  59. [67]

    & Jiao, X

    Liu, D., Wang, J., Xu, Z., Chen, X. & Jiao, X. Phagocytosis: strategies for macrophages to hunt Mycobacterium tuberculosis. One Health Adv. 2, 32 (2024)

    2024

  60. [68]

    Kostic, A. D. et al. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe 14, 207–215 (2013)

    2013

  61. [69]

    Jiang, L. et al. Salmonella Typhimurium reprograms macrophage metabolism via T3SS effector SopE2 to promote intracellular replication and virulence. Nat. Commun. 12, 879 (2021)

    2021

  62. [70]

    https://onlinelibrary-wiley-com.libproxy.unl.edu/doi/10.1111/jdv.19899

    Endothelial dysfunction of syphilis: Pathogenesis - Liu - 2024 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library. https://onlinelibrary-wiley-com.libproxy.unl.edu/doi/10.1111/jdv.19899

    2024 doi

  63. [71]

    Quillin, S. J. & Seifert, H. S. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat. Rev. Microbiol. 16, 226–240 (2018)

    2018

  64. [72]

    https://journals.asm.org/doi/10.1128/jb.00728-17

    Staphylococcus aureus Utilizes Host-Derived Lipoprotein Particles as Sources of Fatty Acids | Journal of Bacteriology. https://journals.asm.org/doi/10.1128/jb.00728-17

    doi

  65. [73]

    A., Wozniak, D

    Gheorghita, A. A., Wozniak, D. J., Parsek, M. R. & Howell, P. L. Pseudomonas aeruginosa biofilm exopolysaccharides: assembly, function, and degradation. FEMS Microbiol. Rev. 47, fuad060 (2023)

    2023

  66. [74]

    Shahreen, N., Chowdhury, N. B. & Saha, R. Optimal protein allocation controls the inhibition of GltA and AcnB in Neisseria gonorrhoeae. Pathog. Dis. 82, ftae023 (2024)

    2024

  67. [75]

    B., Stone, E., Knobbe, E

    Shahreen, N., Chowdhury, N. B., Stone, E., Knobbe, E. & Saha, R. Enzyme- constrained metabolic model of Treponema pallidum identified glycerol-3- phosphate dehydrogenase as an alternate electron sink. mSystems 10, e01555- 24 (2025)

    2025

  68. [76]

    Shahreen, N. et al. A thermodynamic bottleneck in the TCA cycle contributes to acetate overflow in Staphylococcus aureus. mSphere 0, e00883-24 (2024)

    2024

  69. [77]

    Richelle, A., Chiang, A. W. T., Kuo, C.-C. & Lewis, N. E. Increasing consensus of context-specific metabolic models by integrating data-inferred cell functions. PLOS Comput. Biol. 15, e1006867 (2019)

    2019

  70. [78]

    https://www.pnas.org/doi/full/10.1073/pnas.1218599110

    Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production | PNAS. https://www.pnas.org/doi/full/10.1073/pnas.1218599110

    doi

  71. [79]

    & McFadden, G

    Bell, J. & McFadden, G. Viruses for Tumor Therapy. Cell Host Microbe 15, 260–265 (2014)

    2014

  72. [80]

    Cheng, S.-C. et al. mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014)

    2014

  73. [81]

    Alves, R. et al. Adapting to survive: How Candida overcomes host-imposed constraints during human colonization. PLOS Pathog. 16, e1008478 (2020)

    2020

  74. [82]

    Bando, H. et al. Toxoplasma Effector TgIST Targets Host IDO1 to Antagonize the IFN-γ-Induced Anti-parasitic Response in Human Cells. Front. Immunol. 9, (2018)

    2018

  75. [83]

    Pernas, L., Bean, C., Boothroyd, J. C. & Scorrano, L. Mitochondria Restrict Growth of the Intracellular Parasite Toxoplasma gondii by Limiting Its Uptake of Fatty Acids. Cell Metab. 27, 886-897.e4 (2018)

    2018

  76. [84]

    Li, X. et al. Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. Nat. Immunol. 17, 806–815 (2016)

    2016

  77. [85]

    A., Pérez-Torres, A., Escalona-Montaño, A

    Wilkins-Rodríguez, A. A., Pérez-Torres, A., Escalona-Montaño, A. R. & Gutiérrez-Kobeh, L. Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishman...

    2020 doi

  78. [86]

    https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.100037 1

    Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis | PLOS Pathogens. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.100037 1

    doi

  79. [87]

    Khateb, A. et al. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. Nat. Commun. 12, 5397 (2021)

    2021

  80. [88]

    https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1004261

    Metabolic Needs and Capabilities of Toxoplasma gondii through Combined Computational and Experimental Analysis | PLOS Computational Biology. https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1004261

    doi

  81. [89]

    Mayeuf-Louchart, A. et al. Glycogen Dynamics Drives Lipid Droplet Biogenesis during Brown Adipocyte Differentiation. Cell Rep. 29, 1410- 1418.e6 (2019)

    2019

  82. [90]

    Pająk, B. et al. The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D- Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses. Molecules 27, 5928 (2022)

    2022

  83. [91]

    Singhal, A. et al. Metformin as adjunct antituberculosis therapy. Sci. Transl. Med. 6, 263ra159-263ra159 (2014)

    2014

  84. [92]

    https://onlinelibrary-wiley-com.libproxy.unl.edu/doi/10.1155/2015/205016

    Arginine Adjunctive Therapy in Active Tuberculosis - Farazi - 2015 - Tuberculosis Research and Treatment - Wiley Online Library. https://onlinelibrary-wiley-com.libproxy.unl.edu/doi/10.1155/2015/205016

    2015 doi

  85. [93]

    Ralph, A. P. et al. L-arginine and Vitamin D Adjunctive Therapies in Pulmonary Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled Trial. PLOS ONE 8, e70032 (2013)

    2013

  86. [94]

    https://academic-oup-com.libproxy.unl.edu/jid/article/209/5/754/887612

    Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation | The Journal of Infectious Diseases | Oxford Academic. https://academic-oup-com.libproxy.unl.edu/jid/article/209/5/754/887612

  87. [95]

    Dutta, N. K. et al. Statin adjunctive therapy shortens the duration of TB treatment in mice. J. Antimicrob. Chemother. 71, 1570–1577 (2016)

    2016

  88. [96]

    A., Wilkinson, M

    Robinson, G. A., Wilkinson, M. G. Ll. & Wincup, C. The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus. Front. Immunol. 12, 806560 (2022)

    2022

  89. [97]

    Pålsson-McDermott, E. M. & O’Neill, L. A. J. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 30, 300–314 (2020)

    2020

  90. [98]

    Lu, Y. et al. Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases. Front. Immunol. 16, 1536020 (2025)

    2025

  91. [99]

    Pfefferkorn, E. R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. 81, 908–912 (1984)

    1984

  92. [100]

    & Zhao, H

    Xiao, Y., Li, Y. & Zhao, H. Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective. Mol. Cancer 23, 202 (2024)

    2024

  93. [101]

    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268889

    Dual transcriptome based reconstruction of Salmonella-human integrated metabolic network to screen potential drug targets | PLOS One. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268889

    doi

  94. [102]

    S., Kumar, D., Soni, V

    Rawat, B. S., Kumar, D., Soni, V. & Rosenn, E. H. Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination. Vaccines 10, 2127 (2022)

    2022

  95. [103]

    Thomas, T. et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, (2020)

    2020

  96. [104]

    immunometabolism

    Park, J. et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway. Mucosal Immunol. 8, 80–93 (2015). Figure Legends: Figure 1: The figure highlights the contribution of metabolism t...

    2015

Pith tools

Reviewed August 7, 2026 · model on record in the stance chip above.